Osceola Gold (OTC:OSCI) Stock, Quote.Headers.trade-ideas

Osceola Gold Inc is engaged in gold mining activities in the Osceola mining district in Mary Ann Canyon in White Pine County, Nevada.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

AAMMF

ACNNF

ACRT

AGFAF

AGTEF

AGTK

ALTERNATE HEALTH CORP ORD by Alternate Health Corp.

AHGIF

APPB

APRAF

ASCBQ

ASCJF

ASRRF

AWSM

AXCG

BIEI

BITRF

BKFCF

BKPPF

BKQNY

BLILF

BLKCF

BLOZF

BSRC

BTCY

CABA

CADMF

CASXF

CELZ

CERS

CETX

CGOTF

CHXMF

CKPT

CLYYF

CNAB

CONN

CPAI

CRUUF

CWVWF

CXRXF

DAUGF

DELRF

DGRI

DIGAF

DLUEY

DMHI

DPWW

DYNR

DYNT

EESE

ELLXF

ELRA

ENDV

ENRT

ESEA

EVTI

FAMI

FEIM

FNCTF

FRIVF

FSSN

FTFT

GAILF

GALT

GARS

GLYE

GNLN

GTEC

GTEH

GVLMF

HCMC

HGEN

HRCXF

HRVOF

HSNGY

HYSNF

ICNAF

IDRA

IFLM

IFRTF

IMMG

IPSEY

IPUB

IWSY

IZEA

JFIN

JILL

JTBK

KGET

KPAY

KPLUY

LATF

LEGE

LFER

LMPRF

Stocks That Hit 52-Week Lows On Tuesday

Osceola Gold Inc

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Pharming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) with a Buy and maintains $37 price target.

Price Target

Reiteration

Analyst Ratings

PHAR

HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target

&nbsp;Escalade, Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESCA#NASDAQ">ESCA</a>) a leading manufacturer and distributor of sporting goods, recreation equipment, and fitness equipment, is proud to announce a new partnership for its US Weight subsidiary as the official U.S. distributor of adidas Fitness accessories. This exciting addition bolsters US Weight's growing portfolio of fitness brands, which already includes industry leaders Lifeline Fitness, US Weight, and The Step.

ADDYY

ESCA

Escalade Subsidiary US Weight Names Official U.S. Distributor Of Adidas Fitness Accessories

Impact BioMedical Reports Milestone In Its Linebacker Technology Platform; Reports Issuance Of Canadian Patent For Linebacker Technology Targeting Inflammatory Disease

<figure class="table"> 
<table>
<tbody>
<tr>
<td>Global</td>
<td>•&nbsp;September 2024 Quarter AUD$1.5 million up 13% on prior quarter &nbsp;</td>
</tr>
<tr>
<td>Australia &nbsp;</td>
<td>•&nbsp;September 2024 Quarter AUD$1.0 million up 3% on prior quarter &nbsp;</td>
</tr>
<tr>
<td>North America &nbsp;</td>
<td>•&nbsp;September 2024 Quarter AUD$0.5 million up 48% on prior quarter &nbsp;</td>
</tr>
</tbody>
</table>
</figure>

Earnings

Health Care

IMRN

Immuron Announces Sales (Unaudited) Of Travelan A$1.5M, Up 13% Prior Quarter, An OTC Immune Supplement Targeting Pathogenic Bacteria And Toxins Produced In The Gastrointestinal Tract

AKAM

Akamai Enters Collaboration With Kyndryl To Deliver Micro-segmentation Implementation Services With Akamai Guardicore Segmentation

TD Cowen analyst Gabe Daoud upgrades SM Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SM#NYSE">SM</a>) from Hold to Buy and lowers the price target from $64 to $60.

Upgrades

TD Cowen Upgrades SM Energy to Buy, Lowers Price Target to $60

&nbsp;Torontonians, here's the news you've been waiting for - Shake Shack is now available for delivery and pickup, exclusively on Skip! That's right! Skip, Canada's homegrown delivery network, is delighted to announce the addition of Shake Shack to its growing roster of iconic brands and restaurants.
As Shake Shack's exclusive delivery partner, Skip is bringing the ultimate convenience to Torontonians, making it easier than ever to enjoy Shake Shack, delivered right to doorsteps, couches and dining tables across the city.
&nbsp;
"We're thrilled to officially welcome Shake Shack to the Skip network as their exclusive delivery partner," said Rob Payne, Senior Vice President of Partnerships at Skip. "As part of our ambition to provide Canadians with unparalleled convenience, Shake Shack is a fantastic addition to our expanding lineup of renowned restaurant brands in Toronto, giving our customers exclusive access to its iconic menu, with ShackBurgers, crinkle-cut fries and more now delivering to neighbourhoods across the city!"
The global burger chain launched in Canada earlier this year, with its first location in Toronto at the corner of Yonge and Dundas. Since opening, it has drawn massive lines, but now, thanks to Skip, you can enjoy Shack classics like, 100% Canadian Angus beef burgers and crispy chicken—both fresh, never frozen, and raised without antibiotics or added hormones—alongside crispy crinkle-cut fries and hand-spun frozen custard, all from the comfort of your own home. Whether you're in The Annex, King West, Yorkville, Queen West, or Cabbagetown, Shake Shack is just a tap away - only on Skip!
"We're thrilled to partner with Skip to bring Shake Shack to even more Torontonians. As Canada's homegrown delivery network, Skip truly understands Canadian cities and their communities, making them best equipped to serve up the Shack experience to customers across the city," said Billy Richmond, Business Director at Shake Shack Canada. "Since our Toronto opening, we've been delighted with the reception from our guests, and with Skip's help, we're so excited to offer our customers the convenience of their Shack favourites, delivered right to their homes."
Now exclusively available through Skip, satisfying your lunch, dinner, or late-night cravings has never been easier—bringing the Shake Shack experience right to your home!

SHAK

Skip Partners with Shake Shack for Exclusive Toronto Delivery

MVIS

MicroVision Strengthens Financial Position By Closing On Two-year $75M Senior Secured Convertible Note Facility With High Trail Capital

<ul>
<li>Grew Testing Services volume to approximately 44,600, an increase of approximately 16% year-over-year.</li>
<li>Testing services revenue is expected to be in the range of $60 million to $61 million, an increase of approximately 26% year-over-year. This includes approximately $1.2 million in revenue for tests performed in prior quarters.</li>
<li>Patient and Digital Solutions revenue is expected to be approximately $11.9 million, and Products is expected to be approximately $10.2 million, up 20% and 7% year-over-year, respectively.</li>
<li>Ended the quarter with cash, cash equivalents, and marketable securities of approximately $240 million with no debt.</li>
</ul>

CDNA

CareDx Expects Third Quarter 2024 Revenue Of $82M-$83M, Up Approximately 23% YoY, Versus Consensus Of $79.53M

On Tuesday, Nvidia rival Wolfspeed Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) and the U.S. Department of Commerce signed a preliminary memorandum of terms for up to $750 million in funding under the CHIPS and Science Act. This announcement led to a surge in Wolfspeed&#8217;s stock, which rose over 16% in pre-market trading.
What Happened: As per <a href="https://pro.benzinga.com">Benzinga Pro</a>, Wolfspeed&#8217;s stock was trading at $13.28, marking a 16.70% increase from its previous close of $11.38. The funding aims to support Wolfspeed&#8217;s long-term growth and enhance domestic production of silicon carbide, a critical component for electric vehicles, AI data centers, and battery storage systems.
Additionally, a consortium led by Apollo, The Baupost Group, Fidelity Management &amp; Research Company, and Capital Group has agreed to provide Wolfspeed with an extra $750 million in financing, Business Wire noted. This brings Wolfspeed&#8217;s potential capital access to $2.5 billion, including expected tax refunds, to expand silicon carbide manufacturing in the U.S.
See Also: <a href="https://www.benzinga.com/news/24/10/41306527/apples-low-cost-vision-pro-could-hit-the-shelves-next-year-everything-you-need-to-know-about-iphone?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Apple&#8217;s Low-Cost Vision Pro Could Hit The Shelves Next Year — Everything You Need To Know About iPhone Maker&#8217;s Plan To Challenge Meta</a>
Why It Matters: The Biden administration has been actively working to strengthen the U.S. semiconductor industry. The <a href="https://www.benzinga.com/topic/chips-act">CHIPS and Science Act</a> was formalized in 2022 which earmarked $39 billion in grants for U.S. chipmaking and $11 billion for semiconductor research, including the NSTC.
In October, President Joe Biden signed a law to exempt certain U.S. chipmaking facilities from federal environmental reviews. This legislation, under the CHIPS Act, aims to prevent delays from <a href="https://www.benzinga.com/markets/equities/24/10/41158922/biden-signs-law-to-exempt-certain-us-chipmaking-facilities-from-federal-environmental-reviews-un">additional federal reviews</a>, ensuring projects comply with existing regulations. These efforts highlight the government&#8217;s commitment to bolstering the semiconductor supply chain and maintaining the U.S.&#8217;s competitive edge in the global market.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41309072/apple-poured-1b-a-year-into-its-car-project-before-abandoning-it-tim-cooks-company-now-pulls-plug-on?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Apple Poured $1B A Year Into Its Car Project Before Abandoning It. Tim Cook&#8217;s Company Now Pulls Plug On Autonomous Vehicle Testing Permit In California: Here&#8217;s More</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Pre-Market Outlook

Tech

WOLF

This Chipmaker Jumps Over 16% After Nvidia Rival Signs $750M Deal Under Biden's CHIPS And Science Act

BTIG analyst Gregory Lewis initiates coverage on DHT Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHT#NYSE">DHT</a>) with a Buy rating and announces Price Target of $16.

Initiation

BTIG Initiates Coverage On DHT Holdings with Buy Rating, Announces Price Target of $16

Klotho Neurosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>), a U.S.-based biotechnology company pioneering cell and gene therapies for aging and age-related diseases, today announced the appointment of Peter Moriarty, Co-Founder of Shire Pharmaceuticals, as its Chief Operating Officer (COO).
Dr. Joseph Sinkule, Chairman, CEO, and Founder of Klotho Neurosciences, welcomed Moriarty to the leadership team: "We are thrilled to have Peter join Klotho Neurosciences as COO. His extensive experience across the pharmaceutical industry, both in the U.S. and globally, will be instrumental as we move forward. Peter has a remarkable track record, including leadership roles at multinational pharmaceutical companies in the US and internationally and an entrepreneurial career highlighted by his co-founding of Shire Pharmaceuticals. He brings a wealth of expertise in operational management, strategic execution, and cultivating corporate culture—assets that will be critical as we advance our pipeline of innovative therapies."

Management

KLTO

Klotho Neurosciences Tapped Peter Moriarty Of Shire Pharma As COO

Pursuant to the Agreement, NIP Group will issue new shares, at a consideration of RMB23.2 million (approximately US$3.3 million), in exchange for&nbsp;61%&nbsp;of the equity stake in ZSZQ Limited, the Cayman parent company that controls Young Will.
The Agreement was entered into by and among NIP Group, and the beneficial owners of ZSZQ Limited. NIP Group will subsequently acquire an additional&nbsp;13%&nbsp;of the shares of ZSZQ Limited each year during 2025, 2026, and 2027, and in exchange issue a corresponding number of its own shares to the beneficial owners of ZSZQ Limited in accordance with the Agreement, contingent on the satisfaction of certain conditions.
The transaction is expected to close in 2027, subject to the satisfaction of customary closing conditions. This phased acquisition structure demonstrates NIP Group&#39;s long-term commitment to integrating and growing Young Will&#39;s business within its ecosystem.

NIPG

NIP Group Signs Definitive Deal To Acquire Talent Management Company Wuhan Young Will

Among factors contributing to the increase were the previously noted CMS Medicare funding reductions, medical reserve development effects and business and member mix. The company did not have any favorable earnings impacting medical reserve development in the quarter.&nbsp;

Large Cap

UnitedHealth Reports Q3 2024 Medical Care Ratio Of 85.2% Compared To 82.3% Last Year

TotalEnergies SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTE#NYSE">TTE</a>) shares are trading lower premarket on Tuesday. The company announced that it expects its hydrocarbon production levels in the <a target="_blank" href="https://totalenergies.com/investors/main-indicators" rel="noreferrer noopener">third </a>quarter to be around 2.4 Mboe/d, led by the ramp-up of the Mero 2 project in Brazil.
TotalEnergies expects this to offset unplanned shutdowns at Ichthys LNG and security disruptions in Libya.
Exploration &amp; Production results are anticipated to reflect lower liquid prices, offset by higher gas prices.
TotalEnergies projects Integrated LNG results to exceed $1 billion despite reduced production from Ichthys LNG maintenance and low market volatility.
Also, the company expects Integrated Power to remain steady with the second quarter levels, while Downstream results are expected to decline significantly due to lower refining margins in Europe and globally.
This month, the company stated that it plans annual net investments of $16 billion – $18 billion from 2025 to 2030, with around $5 billion for low-carbon energies, allowing for a $2 billion reduction in case&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/10/41147964/totalenergies-bets-big-on-expansion-lng-renewables-and-billions-in-buybacks" rel="noreferrer noopener">of significant price declines</a>.
Last week, the company agreed to acquire a 50% stake in two offshore wind projects in the North Sea from&nbsp;RWE AG, specifically N-9.1 and N-9.2, <a target="_blank" href="https://www.benzinga.com/markets/equities/24/10/41210034/totalenergies-acquires-50-stake-in-two-offshore-wind-projects-in-north-sea-details" rel="noreferrer noopener">each with a&nbsp;capacity&nbsp;of 2 GW</a>.
TotalEnergies expects to report third quarter 2024 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">results on October 31.</a>
Investors can gain exposure to the stock via&nbsp;Advisor Managed Portfolios Miller Value Partners Appreciation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MVPA#NYSE">MVPA</a>) and&nbsp;Octane All-Cap Value Energy ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCTA#NASDAQ">OCTA</a>).
Price Action: TTE shares are down 3.99% at $65.39 premarket at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41225523/totalenergies-locks-in-renewable-electricity-supply-deal-with-saint-gobain" target="_blank" rel="noreferrer noopener">TotalEnergies Locks In Renewable Electricity Supply Deal With Saint-Gobain</a></li>
</ul>

Equities

Guidance

MVPA

OCTA

Why Is TotalEnergies Stock Sliding Today?

The company's adjusted net earnings outlook of $27.50 to $27.75 continues within the $27.50 to $28.00 range established nearly a year ago, even as it absorbs an estimated $0.75 per share of business disruption impacts for the affected Change Healthcare services, which have increased ~$0.10 per share from the estimate provided last quarter.&nbsp;

UnitedHealth Expects 2024 Adjusted EPS To $27.50-$27.75 Compared To Prior Guidance Of $27.50-$28.00 Versus Consensus Of $27.70

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates UroGen Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>) with a Buy and maintains $60 price target.

URGN

HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $60 Price Target

UnitedHealth Group Q3 2024 Adj. EPS $7.15 Beats $7.00 Estimate, Sales $100.800B Beat $99.279B Estimate

Cybertruck lead engineer Wes Morrill on Monday mocked Fiat USA&#8216;s new ad for the Fiat 500e, comparing and contrasting the small EV with Tesla Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) <a href="https://www.benzinga.com/news/24/09/40849409/former-top-gear-host-james-may-thinks-a-vehicle-the-size-of-a-fiat-panda-but-styled-like-tesla-cyber">sole EV truck in production</a>, terming it as an attempt by the Fiat media team to drive the EV giant&#8217;s stainless steel vehicle.
What Happened: &#8220;The Fiat media team just wanted a reason to drive a Cybertruck as a benchmark for their ad,&#8221; Morrill said about the ad which contrasts the Fiat 500e with the Cybertruck.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Fiat really nailed this Cybertruck ad <a href="https://t.co/TLGvFVeVA3">https://t.co/TLGvFVeVA3</a>
&mdash; Wes (@wmorrill3) <a href="https://twitter.com/wmorrill3/status/1846002988185539032?ref_src=twsrc%5Etfw">October 15, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Morrill also alleged that the ad promotes Cybertruck more than it promotes Fiat&#8217;s own EV. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The Fiat media team just wanted a reason to drive a Cybertruck as a benchmark for their ad
&mdash; Wes (@wmorrill3) <a href="https://twitter.com/wmorrill3/status/1846038526380724358?ref_src=twsrc%5Etfw">October 15, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
&#8220;Do you think this ad will generate more Cybertruck sales or 500e sales,&#8221; the engineer asked while adding that Fiat &#8220;really nailed&#8221; the Cybertruck.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Do you think this ad will generate more Cybertruck sales or 500e sales &#x1f914;
&mdash; Wes (@wmorrill3) <a href="https://twitter.com/wmorrill3/status/1846038808657383549?ref_src=twsrc%5Etfw">October 15, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
About The Ad: Fiat USA shared the ad on YouTube about two weeks ago. The ad is titled &#8220;You Say Tomato, We Say Pomodoro,&#8221; referring to Fiat&#8217;s Italian roots.
The all-electric FIAT 500e is what an electric car should be, the company said about its small EV in the ad. 
The ad goes on to contrast the Fiat EV with the Cybertruck, noting differences in public perception and ease of parking. While the Cybertruck shocks with its appearance and is difficult to park, the Fiat 500e is cute and small, the ad claims. 
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="You Say Tomato, We Say Pomodoro" width="500" height="281" src="https://www.youtube.com/embed/S-oZM6BE320?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Why It Matters: The Fiat 500e is the only EV from the Italian automaker sold in the U.S. The 2024 model-year vehicle has a starting price of about $33,000, low when compared to the Tesla Foundation series Cybertruck which has a starting price of about $100,000. 
In the third quarter, Fiat <a href="https://www.benzinga.com/news/24/10/41114420/stellantis-extends-fiat-500-electric-production-halt-due-to-low-demand">sold just 235 units of the 500e</a> in the U.S. while Tesla sold 16,692 Cybertrucks, according to estimates from automotive research company Kelley Blue Book.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read More:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41324450/elon-musk-says-spacexs-next-generation-starlink-satellites-will-be-so-big-that-only-starship-can-lau">Elon Musk Says SpaceX&#8217;s Next-Generation Starlink Satellites Will Be &#8216;So Big That Only Starship Can Launch Them:&#8217; Will Offer 10X Increase In Bandwidth And Reduced Latency</a></li>
</ul>
Photos courtesy: Fiat and Wikimedia

TSLA

Tesla Exec Mocks Stellantis' Fiat For New Commercial Comparing Fiat 500e With Cybertruck: '...Really Nailed This...'

HC Wainwright &amp; Co. analyst Edward White reiterates Dynavax Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DVAX#NASDAQ">DVAX</a>) with a Buy and maintains $29 price target.

DVAX

HC Wainwright & Co. Reiterates Buy on Dynavax Technologies, Maintains $29 Price Target

Osceola Gold inks multi-year agreement to expand mining operations in Nevada

OSCI

Press Releases

Osceola Gold Announces Successful First Month of Operations and Progress Update on Gold Yield and Geology Report

Osceola Gold Continues Search for CEO as New Geological Report Reveals Promising Results

Osceola Gold Announces Winter Closure and Exciting Progress in Gold Excavation

Osceola Gold Explores New Potential Acquisition for This Summer

Osceola Gold Inc. Inks Strategic Multi-Year Agreement to Expand Mining Operations in Mary Ann Canyon, Nevada

Osceola Gold

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

Osceola Gold

Osceola Gold (OSCI) Forecast

Osceola Gold (OTC:OSCI) Stock, Quote.Headers.trade-ideas